Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01320072 · ClinicalTrials.gov registry record
Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
A clinical trial, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- 29
- Enrollment target
NCT01320072: Clinical Trial study, sponsored by Montefiore Medical Center.
NCT01320072 is a clinical trial that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01320072 was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
To diagnose aspirin hypersensitivity in asthmatics by using and safe, low-dose aspirin oral challenge. Hypothesis 1: A low dose of oral ASA (20 or 40 mg) will induce significantly different concentrations of arachidonic acid metabolites in ASA-sensitive asthmatics as compared to ASA-tolerant asthmatics. Hypothesis 2: The low dose (20 or 40 mg) ASA challenge will be well tolerated by ASA-sensitive asthmatics.
Primary Outcome
eicosanoid metabolites concentration in plasma and urine 2 h post ASA challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2010-05 |
| Est. Completion | 2022-05-26 |
Why NCT01320072 stopped before completion
NCT01320072 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01320072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01320072 about?
NCT01320072 is a clinical study titled "Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease". To diagnose aspirin hypersensitivity in asthmatics by using and safe, low-dose aspirin oral challenge. Hypothesis 1: A low dose of oral ASA (20 or 40 mg) will induce significantly different concentrations of arachidonic acid metabolites in ASA-sensitive asthmatics as compared to ASA-tolerant asthma...
What is the current status of trial NCT01320072?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2010-05. Estimated completion is 2022-05-26.
Who is sponsoring clinical trial NCT01320072?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia